Literature DB >> 14500342

Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors.

Neil S Forbes1, Lance L Munn, Dai Fukumura, Rakesh K Jain.   

Abstract

Blood-borne therapeutics, which rely on diffusion and convection for delivery, often do not accumulate in effective concentrations distant from vasculature and are therefore unable to eradicate all cells within a tumor. Motile bacteria have the potential to overcome the diffusion and pressure gradients that prevent passive materials from penetrating into poorly perfused regions of tumors. Here, we test several proposed mechanisms of Salmonella typhimurium accumulation in tumors, including: (a) entrapment in the chaotic vasculature of tumors; (b) attraction to specific tumor microenvironments; and (c) preferential replication within specific microenvironments. After systemic injection of S. typhimurium into tumor-bearing mice, we used intravital microscopy and histological techniques to quantify their interaction with tumor vasculature. Immediately after injection, few S. typhimurium (<4 in 10,000) adhered to tumor vasculature; most remained passively suspended in the blood. Despite this low initial adhesion, approximately 10,000-fold more S. typhimurium accumulated in tumors than any other organ 1 week after the injection, thus demonstrating their specificity. However, within the tumors, we found that most bacteria were located in necrotic tissue as large colonies far (750 micro m) from functional vasculature. Together, these results suggest that S. typhimurium has limited ability to adhere to tumor vasculature and migrate within tumors and only survives in tissue that becomes necrotic. Although S. typhimurium is a promising delivery vehicle because of its tumor specificity, increasing its intra-tumoral motility should improve its therapeutic effectiveness.

Entities:  

Mesh:

Year:  2003        PMID: 14500342

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  55 in total

1.  A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy.

Authors:  Kelly Flentie; Brandon Kocher; Seth T Gammon; Deborah V Novack; Jeffrey S McKinney; David Piwnica-Worms
Journal:  Cancer Discov       Date:  2012-05-03       Impact factor: 39.397

Review 2.  Tumour-targeting bacteria engineered to fight cancer.

Authors:  Shibin Zhou; Claudia Gravekamp; David Bermudes; Ke Liu
Journal:  Nat Rev Cancer       Date:  2018-12       Impact factor: 60.716

3.  Persistent enhancement of bacterial motility increases tumor penetration.

Authors:  Dana N Thornlow; Emily L Brackett; Jonathan M Gigas; Nele Van Dessel; Neil S Forbes
Journal:  Biotechnol Bioeng       Date:  2015-09-04       Impact factor: 4.530

4.  Engineered bacteria detect spatial profiles in glucose concentration within solid tumor cell masses.

Authors:  Jan T Panteli; Neil S Forbes
Journal:  Biotechnol Bioeng       Date:  2016-09-20       Impact factor: 4.530

Review 5.  Potent and tumor specific: arming bacteria with therapeutic proteins.

Authors:  Nele Van Dessel; Charles A Swofford; Neil S Forbes
Journal:  Ther Deliv       Date:  2015-03

6.  Motility is critical for effective distribution and accumulation of bacteria in tumor tissue.

Authors:  Bhushan J Toley; Neil S Forbes
Journal:  Integr Biol (Camb)       Date:  2011-12-22       Impact factor: 2.192

7.  Shigella mediated depletion of macrophages in a murine breast cancer model is associated with tumor regression.

Authors:  Katharina Galmbacher; Martin Heisig; Christian Hotz; Joerg Wischhusen; Antoine Galmiche; Birgit Bergmann; Ivaylo Gentschev; Werner Goebel; Ulf R Rapp; Joachim Fensterle
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

Review 8.  Bacterial therapies: completing the cancer treatment toolbox.

Authors:  Adam T St Jean; Miaomin Zhang; Neil S Forbes
Journal:  Curr Opin Biotechnol       Date:  2008-09-18       Impact factor: 9.740

9.  Improving tumor targeting and therapeutic potential of Salmonella VNP20009 by displaying cell surface CEA-specific antibodies.

Authors:  Michal Bereta; Andrew Hayhurst; Mariusz Gajda; Paulina Chorobik; Marta Targosz; Janusz Marcinkiewicz; Howard L Kaufman
Journal:  Vaccine       Date:  2007-03-22       Impact factor: 3.641

10.  Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice.

Authors:  S Ganai; R B Arenas; N S Forbes
Journal:  Br J Cancer       Date:  2009-10-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.